National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
In English | En español
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
 Display for Print  New Search
 
Results: 1 -7 of 7         results per page
 View Search Criteria | Help With Results
           

1.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II
Treatment
Active
18 and over
Pharmaceutical / Industry
A3671008
NCT00254579

Last Modified: 5/22/2008     First Published: 5/4/2007  

2.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II
Biomarker/Laboratory analysis, Treatment
Active
Not specified
Other, Pharmaceutical / Industry
UCLA-0606093-01
06-06-093-01, PFIZER-UCLA-0606093-01, NCT00471887


3.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase I
Treatment
Active
18 and over
Pharmaceutical / Industry
A3671025
NCT00372853


4.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase I
Treatment
Active
18 and over
Pharmaceutical / Industry
A3671016
NCT00556023


5.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase I
Treatment
Active
18 and over
Pharmaceutical / Industry
A3671022
NCT00585000


6.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase I
Treatment
Active
18 and over
Other
H2008-0086
CO07808, NCT00702923


7.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

No phase specified
Treatment
Active
18 and over
Pharmaceutical / Industry
A3671024
NCT00378482

   
  Display for Print   New Search

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov